Literature DB >> 27720208

Clinical characteristics and treatment outcomes of pulmonary disease caused by Mycobacterium chimaera.

Seong Mi Moon1, Su-Young Kim1, Byung Woo Jhun1, Hyun Lee1, Hye Yun Park1, Kyeongman Jeon1, Hee Jae Huh2, Chang-Seok Ki2, Nam Yong Lee2, Sung Jae Shin3, Won-Jung Koh4.   

Abstract

Mycobacterium chimaera is a recently described species distinct from M. intracellulare. M. chimaera is regarded as less virulent than M. intracellulare. Using multi-locus sequence-based identification, M. chimaera lung disease was diagnosed in 11 patients. Clinical characteristics and outcomes of M. chimaera lung disease were comparable to M. intracellulare lung disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Mycobacterium avium complex; Mycobacterium chimaera; Mycobacterium intracellulare; Nontuberculous mycobacteria

Mesh：

Year:  2016        PMID： 27720208     DOI： 10.1016/j.diagmicrobio.2016.09.016

Source DB:  PubMed          Journal:  Diagn Microbiol Infect Dis        ISSN： 0732-8893            Impact factor:   2.803


  6 in total

1.  Intermittent Antibiotic Therapy for Recurrent Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.

Authors:  Byung Woo Jhun; Seong Mi Moon; Su-Young Kim; Hye Yun Park; Kyeongman Jeon; O Jung Kwon; Hee Jae Huh; Chang-Seok Ki; Nam Yong Lee; Myung Jin Chung; Kyung Soo Lee; Sung Jae Shin; Charles L Daley; Won-Jung Koh
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

2.  Target-Specific Assay for Rapid and Quantitative Detection of Mycobacterium chimaera DNA.

Authors:  Enrique Zozaya-Valdés; Jessica L Porter; John Coventry; Janet A M Fyfe; Glen P Carter; Anders Gonçalves da Silva; Mark B Schultz; Torsten Seemann; Paul D R Johnson; Andrew J Stewardson; Ivan Bastian; Sally A Roberts; Benjamin P Howden; Deborah A Williamson; Timothy P Stinear
Journal:  J Clin Microbiol       Date:  2017-04-05       Impact factor: 5.948

3.  Clinical implications of Mycobacterium chimaera detection in thermoregulatory devices used for extracorporeal membrane oxygenation (ECMO), Germany, 2015 to 2016.

Authors:  Franziska C Trudzinski; Uwe Schlotthauer; Annegret Kamp; Kai Hennemann; Ralf M Muellenbach; Udo Reischl; Barbara Gärtner; Heinrike Wilkens; Robert Bals; Mathias Herrmann; Philipp M Lepper; Sören L Becker
Journal:  Euro Surveill       Date:  2016-11-17

4.  Mycobacterium chimaera Pulmonary Disease in Cystic Fibrosis Patients, France, 2010-2017.

Authors:  Romaric Larcher; Manon Lounnas; Yann Dumont; Anne-Laure Michon; Lucas Bonzon; Raphael Chiron; Christian Carriere; Kada Klouche; Sylvain Godreuil
Journal:  Emerg Infect Dis       Date:  2019-03       Impact factor: 6.883

5.  Disseminated Mycobacterium chimaera infection in a patient with adult-onset immunodeficiency syndrome: case report.

Authors:  Yi-Fu Lin; Tai-Fen Lee; Un-In Wu; Chun-Fu Huang; Aristine Cheng; Kuan-Yin Lin; Chien-Ching Hung
Journal:  BMC Infect Dis       Date:  2022-08-01       Impact factor: 3.667

6.  Drug Susceptibility of 33 Reference Strains of Slowly Growing Mycobacteria to 19 Antimicrobial Agents.

Authors:  Hui Pang; Yi Jiang; Kanglin Wan
Journal:  Biomed Res Int       Date:  2017-04-20       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.